Tuesday, November 14, 2017
Presenter: Mercedes Perez-Rodriguez, M.D., Ph.D.
The study of personality disorders conceived as categorical entities has traditionally been in the province of psychoanalytic or behavioral models. However, there is an emerging area of study, spearheaded by the NIMH Research Domain Criteria (RDoCs) program, that aims to uncover the neurobiological underpinnings of the dimensions that make up mental disorders. These new directions in psychiatry neurobiological research converge with new dimensional conceptions of personality disorders, and with efforts to identify the neural basis for the traits underlying personality disorders.
Borderline personality disorder (BPD) is characterized by emotional dysregulation, which is linked to a neurobiological model of emotional undermodulation and deficient habituation; and by interpersonal impairments, which are linked to deficits in social cognition. Schizotypal personality disorder (SPD) is comprised of interpersonal and social cognitive abnormalities and cognitive/ perceptual impairments, and shares clinical, cognitive and neurobiological overlap with schizophrenia, as this presentation aims to show.
2 CME/ CE credits offered.
PLEASE call 212-879-7050 to register over the phone for this event.
RSVP-$20 general admission
RSVP-$10 students (non-NYPSI)
RSVP-free for NYPSI members/students
Born and raised in Spain, Dr. M. Mercedes Perez-Rodriguez moved to the U.S. in 2008 to pursue an academic career in psychiatry research. Dr. Perez is Assistant Professor of Psychiatry and Assistant Training Director for Research in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York. She is the Medical Director of the Psychosis Research Integrating Science and Medicine (PRISM) Program.
Dr. Perez’s work, funded by the NIH, the Brain and Behavior Research Foundation (NARSAD), and the VA MIRECC, aims to elucidate the biological underpinnings of psychosis spectrum and personality disorders and test novel treatments through cutting-edge clinical trials, with a focus on cognition and social cognition.
Dr. Perez has authored or co-authored over 100 publications, including more than 70 papers in in peer-reviewed journals and 15 book chapters, and has made more than 60 presentations at national and international meetings.
Dr. Perez is a Fellow Member of the American Psychiatric Association and an Associate Member of the American College of Neuropsychopharmacology (ACNP). She has served in several administrative leadership positions including the National Advisory Mental Health Council Workgroup on Tasks and Measures for RDoC (Research Domain Criteria) at the NIMH; the Innovations Working Group and the Biomarkers Working Group at the International Society for Central Nervous System Clinical Trials Methodology (ISCTM); and the Membership Task Force committee at The American College of Neuropsychopharmacology (ACNP). Dr. Perez is an elected member of the board of directors of the American Society of Hispanic Psychiatry.
Educational Objectives: Upon completion of this activity, participants will be able to:
1. Examine the evidence about clinical, cognitive and neurobiological overlap between schizotypal personality disorder and schizophrenia
2. Describe the social cognitive abnormalities underlying borderline personality disorder
3. Describe the emotional undermodulation/deficient emotional habituation model of borderline personality disorder
Psychologists: New York Psychoanalytic Society & Institute is approved by the American Psychological Association (APA) to sponsor continuing education programs for psychologists. New York Psychoanalytic Society & Institute maintains responsibility for these programs and their content.
Social Workers: New York Psychoanalytic Society & Institute SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0317.
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Psychoanalytic Association and New York Psychoanalytic Society & Institute. The American Psychoanalytic Association is accredited by the ACCME to provide continuing medical education for physicians.
The American Psychoanalytic Association designates this Live Activity for a maximum of (2) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
IMPORTANT DISCLOSURE INFORMATION FOR ALL LEARNERS: None of the planners and presenters of this CME program has any relevant financial relationships to disclose.
Persons with disabilities: The building is wheelchair accessible and has an elevator. Please notify the registrar in advance if you require accommodations.